Trial Search Results

Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer

To determine the safety, feasibility and appropriate dendritic cell dose to vaccinate patients with pancreas cancer

Stanford is currently not accepting patients for this trial.

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jenna Rogers
6507234467
Not Recruiting